SCHEMBL5377004

SCHEMBL5377004

CCCc1c(/C=C/C(=O)OCC)cnn1Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MAPK14 Q16539 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HPGD P15428 1/20 0.44
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
POLB P06746 2/20 0.40
CYP19A1 P11511 1/20 0.40
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
ALOX5 P09917 1/20 0.39
AKR1B10 O60218 1/20 0.39
AKR1B1 P15121 1/20 0.39
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6593864 0.87 SMN1; SMN2 (0.48) NPC1RAB9AMAPK14SMN1; SMN2HPGD
SCHEMBL6593855 0.87 SMN1; SMN2 (0.48) NPC1RAB9AMAPK14SMN1; SMN2HPGD
SCHEMBL5377216 0.83 CYP19A1 (0.51) NPC1RAB9ASMN1; SMN2HPGDALDH1A1
SCHEMBL28757208 0.79 CCNC (0.45) NPC1RAB9ASMN1; SMN2HPGDCCNC
SCHEMBL28757209 0.79 CCNC (0.45) NPC1RAB9ASMN1; SMN2HPGDCCNC
SCHEMBL5377123 0.78 TSHR (0.43) NPC1RAB9AMAPK14SMN1; SMN2HPGD
SCHEMBL5382860 0.78 SMN1; SMN2 (0.58) NPC1MAPK14SMN1; SMN2HPGDALDH1A1
SCHEMBL5377010 0.76 MAPK14 (0.42) NPC1RAB9AMAPK14SMN1; SMN2HPGD
SCHEMBL23400358 0.71 TSHR (0.46) MAPK14SMN1; SMN2HPGDALDH1A1KMT2A
SCHEMBL5377143 0.70 MEN1 (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7179823-B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-20 US disclosed